Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 319 followers

Latest posts

Last updated about 14 hours ago

Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 20, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 11, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation...

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) annual activity report 2025

about 15 hours ago

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) annual...

Minutes of the Management Board meeting: 17-18 December 2025

about 15 hours ago

Minutes of the Management Board meeting: 17-18 December 2025

Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 1, Status: Authorised

about 15 hours ago

Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation...

European Medicines Agency (EMA) stakeholder relations management framework

about 16 hours ago

European Medicines Agency (EMA) stakeholder relations management framework

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 45, Status: Authorised

about 16 hours ago

Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation...

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 8, Status: Authorised

about 17 hours ago

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation...

Standard operating procedure for annual review of VeDDRA list to be used in EudraVigilance Veterinary

about 18 hours ago

Standard operating procedure for annual review of VeDDRA list to be used...

Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation: 18/07/2025, Revision: 1, Status: Authorised

about 18 hours ago

Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation...

Referral: Melatomed and associated names, melatonin Article 29(4) referrals European Commission final decision, 11/12/2025, 18/02/2026, 26/02/2026

about 19 hours ago

Referral: Melatomed and associated names, melatonin Article 29(4) referrals European Commission final...